<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Autism</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Autism</journal-id>
<journal-title-group>
<journal-title>Molecular Autism</journal-title>
</journal-title-group>
<issn pub-type="epub">2040-2392</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30603062</article-id>
<article-id pub-id-type="pmc">6307226</article-id>
<article-id pub-id-type="publisher-id">254</article-id>
<article-id pub-id-type="doi">10.1186/s13229-018-0254-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuroglia in the autistic brain: evidence from a preclinical model</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Bronzuoli</surname>
<given-names>Maria Rosanna</given-names>
</name>
<address>
<email>mariarosanna.bronzuoli@uniroma1.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Facchinetti</surname>
<given-names>Roberta</given-names>
</name>
<address>
<email>roberta.facchinetti@uniroma1.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ingrassia</surname>
<given-names>Davide</given-names>
</name>
<address>
<email>davide91.ingrassia@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarvadio</surname>
<given-names>Michela</given-names>
</name>
<address>
<email>michela.servadio@uniroma3.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schiavi</surname>
<given-names>Sara</given-names>
</name>
<address>
<email>sara.schiavi@uniroma3.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steardo</surname>
<given-names>Luca</given-names>
</name>
<address>
<email>luca.steardo@uniroma1.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>Alexei</given-names>
</name>
<address>
<email>alexej.verkhratsky@manchester.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trezza</surname>
<given-names>Viviana</given-names>
</name>
<address>
<email>viviana.trezza@uniroma3.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7314-1539</contrib-id>
<name>
<surname>Scuderi</surname>
<given-names>Caterina</given-names>
</name>
<address>
<email>caterina.scuderi@uniroma1.it</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.7841.a</institution-id><institution>Department of Physiology and Pharmacology, </institution><institution>“Vittorio Erspamer” SAPIENZA University of Rome, </institution></institution-wrap>00185 Rome, Italy </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121622106</institution-id><institution-id institution-id-type="GRID">grid.8509.4</institution-id><institution>Department of Science, Section of Biomedical Sciences and Technologies, </institution><institution>University “Roma Tre”, </institution></institution-wrap>00154 Rome, Italy </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution>Faculty of Biology, Medicine and Health, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, M13 9PT UK </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Center for Basic and Translational Neuroscience, Faculty of Health and Medical Sciences, </institution><institution>University of Copenhagen, </institution></institution-wrap>2200 Copenhagen, Denmark </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0467 2314</institution-id><institution-id institution-id-type="GRID">grid.424810.b</institution-id><institution>Achucarro Center for Neuroscience, </institution><institution>IKERBASQUE, Basque Foundation for Science, </institution></institution-wrap>48011 Bilbao, Spain </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>66</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Neuroglial cells that provide homeostatic support and form defence of the nervous system contribute to all neurological disorders. We analyzed three major types of neuroglia, astrocytes, oligodendrocytes, and microglia in the brains of an animal model of autism spectrum disorder, in which rats were exposed prenatally to antiepileptic and mood stabilizer drug valproic acid; this model being of acknowledged clinical relevance.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">We tested the autistic-like behaviors of valproic acid-prenatally exposed male rats by performing isolation-induced ultrasonic vocalizations, the three-chamber test, and the hole board test. To account for human infancy, adolescence, and adulthood, such tasks were performed at postnatal day 13, postnatal day 35, and postnatal day 90, respectively. After sacrifice, we examined gene and protein expression of specific markers of neuroglia in hippocampus, prefrontal cortex, and cerebellum, these brain regions being associated with autism spectrum disorder pathogenesis.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">Infant offspring of VPA-exposed dams emitted less ultrasonic vocalizations when isolated from their mothers and siblings and, in adolescence and adulthood, they showed altered sociability in the three chamber test and increased stereotypic behavior in the hole board test. Molecular analyses indicate that prenatal valproic acid exposure affects all types of neuroglia, mainly causing transcriptional modifications. The most prominent changes occur in prefrontal cortex and in the hippocampus of autistic-like animals; these changes are particularly evident during infancy and adolescence, while they appear to be mitigated in adulthood.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Neuroglial pathological phenotype in autism spectrum disorder rat model appears to be rather mild with little signs of widespread and chronic neuroinflammation.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Autism spectrum disorder</kwd>
<kwd>Astrocyte</kwd>
<kwd>Microglia</kwd>
<kwd>Oligodendrocyte</kwd>
<kwd>Valproic acid</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>SAPIENZA University of Rome </institution>
</funding-source>
<award-id>MA116154CD981DAE</award-id>
<principal-award-recipient>
<name>
<surname>Scuderi</surname>
<given-names>Caterina</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Marie Curie Career Reintegration Grant </institution>
</funding-source>
<award-id>PCIG09-GA-2011-293589</award-id>
<principal-award-recipient>
<name>
<surname>Trezza</surname>
<given-names>Viviana</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Jerome Lejeune Foundation Research </institution>
</funding-source>
<award-id>1674</award-id>
<principal-award-recipient>
<name>
<surname>Trezza</surname>
<given-names>Viviana</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par31">Autism spectrum disorder (ASD) is a heterogeneous set of neurodevelopmental disorders characterized by deficits in social communication and social interaction, stereotypies, and reduced patterns of behaviors [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Even though ASD can be diagnosed at any age, symptoms generally appear in the childhood and last throughout a person’s life. Although about 1% of the world population suffers from ASD [<xref ref-type="bibr" rid="CR3">3</xref>], little is known on ASD etiology and pathogenesis. Genetic predispositions, maternal stressors, environmental factors, infectious agents, and the intake of specific drugs during pregnancy all have some degree of association with ASD [<xref ref-type="bibr" rid="CR4">4</xref>]. One of the common environmental factors involved in the pathogenesis of ASD is maternal exposure to the antiepileptic and mood stabilizer drug valproic acid (VPA). When given during pregnancy, VPA was reported to induce various congenital malformations [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] including autistic-like features in the exposed children, such as impaired communication, reduced sociability and stereotyped behaviors [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Based on these clinical observations, prenatal VPA exposure in rodents has been developed and became a widely used environmental preclinical model of ASD with face and construct validity [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par32">Recent findings highlight contribution of neuroglia to the ASD pathophysiology. Glial cells are non-excitable homeostatic cells of the central nervous system (CNS), sub-classified into astrocytes, oligodendrocytes and their precursors (also known as NG-2 glia) and microglia; all types of glia sustain vital brain functions [<xref ref-type="bibr" rid="CR12">12</xref>]<italic>.</italic> Specifically, astroglial cells are key cellular contributors to the homeostasis of the nervous tissue and the brain as an organ [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Astrocytes regulate pH and ion homeostasis, regulate functional hyperaemia and provide trophic and metabolic support to neurones. Astrocytes are important elements of the cytoarchitecture of the brain. These cells are essential for synaptogenesis [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] as well as synaptic remodeling and are likely to contribute to various aspects of memory formation, storage, and retention [<xref ref-type="bibr" rid="CR19">19</xref>]. Oligodendrocytes form the myelin sheath, thus maintaining the functional connectome of the brain and contributing to the optimal information processing in complex neural networks [<xref ref-type="bibr" rid="CR20">20</xref>]. Microglia provide the immune and cellular defence in the brain. Through several surveillance mechanisms, microglia detect diverse pathological extracellular signals, and respond to them to protect the brain. These cells also contribute to the development of the nervous tissue, shaping neuronal ensembles and synaptic plasticity [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]<italic>.</italic></p>
<p id="Par33">Increasing appreciation of the multifaceted physiological roles of glia in the developing and mature CNS suggests that abnormalities in glial functions contribute to neuropathology. Several preclinical models of diseases revealed the role of glia in neurodevelopmental diseases, from ASD to neuropsychiatric disorders. Pathological changes in neuroglia are complex and can be classified into reactive response (astrogliosis, activation of microglia, and Wallerian remodeling of oligodendrocytes), degeneration with atrophy and loss of function (characteristic for astrocytes and microglia), and pathological remodeling [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. The contribution of glial cells to pathological development of cognitive and neuropsychiatric disorders, such as Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, and others, has been demonstrated [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. The role of glia in ASD however is not clear and often the data available are limited to their involvement in the inflammatory response.</p>
<p id="Par34">In this study, we performed an in-depth analysis of gene and protein expression of specific markers of astrocytes, oligodendrocytes, and microglia in the rats prenatally exposed to VPA (ASD animal model). We studied brain areas critically involved in ASD, namely, hippocampus (HPC), prefrontal cortex (PfC), and cerebellum (Cb) [<xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR39">39</xref>]. To account for human infancy, adolescence, and adulthood, brain tissues were analyzed at three different ages, at postnatal day (PND) 13, PND 35, and PND 90. Our results indicate that prenatal VPA exposure affects all types of neuroglia, mainly causing transcriptional modifications. The most significant changes occur in PfC and in the HPC of autistic-like animals; these changes are particularly evident during infancy and adolescence, while they appear to be mitigated in adulthood.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<p id="Par35">All animal procedures were performed in agreement with the guidelines of the Italian Ministry of Health (D.L. 26/2014) and with the European Parliament directive 2010/63/EU.</p>
<sec id="Sec3">
<title>Animals</title>
<p id="Par36">The offspring born from VPA-exposed dams was obtained as described previously [<xref ref-type="bibr" rid="CR40">40</xref>]. Adult female Wistar rats (Charles River, Arbresle, France) were housed and raised under controlled conditions (22 ± 2 °C temperature, 55–65% relative humidity, 12-h light/12-h dark cycle with lights on at 07:00 h) in an enriched environment, with food and water available ad libitum. Rats weighing 250 ± 15 g were mated overnight, and the morning when spermatozoa were found was assigned as gestational day 1 (GD 1). Pregnant rats, singly placed in Macrolon cages (40 × 26 × 20 cm), on GD 12.5, received an intraperitoneal injection of either VPA (500 mg/kg in saline) or saline (Veh). This dose of VPA, administered at this developmental time point, is known to induce autistic-like traits in the exposed rat offspring at infancy, adolescence, and adulthood [<xref ref-type="bibr" rid="CR41">41</xref>]. The day after birth (PND 1), the litters were culled to six males and two females to reduce the litter size-induced variability in the growth and development of pups during the postnatal period. However, epidemiological studies report a higher incidence of ASD in boys than in girls, and it has been shown that the autistic-like-behaviors displayed by rats prenatally exposed to VPA are more pronounced in the male than in the female offspring [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. For these reasons, only the male offspring was used in this study. After weaning on PND 21, pups were weaned and housed in groups of three. In order to perform the molecular analysis of the brains in infancy, adolescence, and adulthood, the male offspring (one rat/litter/treatment) was sacrificed on PND 13, PND 35, and PND 90, respectively. After decapitation, PfC, HPC, and Cb were rapidly isolated to perform western blot and real time-quantitative PCR (RT-qPCR); whereas, whole brains for immunofluorescence were flash-frozen in 2-methylbutane and stored at − 80 °C. The experimental design is outlined in Fig. <xref ref-type="fig" rid="Fig1">1</xref>a.<fig id="Fig1"><label>Fig. 1</label><caption><p>Effect of prenatal VPA exposure on animals’ behavior. Schematic representation of the experimental design (<bold>a</bold>). Assessment of the autistic-like phenotype in prenatally VPA-exposed rats through reduced isolation-induced USV emission at PND 13 (<bold>b</bold>), sociability in the three-chamber test at PND 35 (<bold>c</bold>), and induced stereotypic behavior in the hole-board test at PND 90 (<bold>d</bold>) (Veh <italic>n</italic> = 5, VPA <italic>n</italic> = 5). Data represent mean ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05 vs Veh group)</p></caption><graphic id="MO1" xlink:href="13229_2018_254_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec4">
<title>Behavioral tests</title>
<sec id="Sec5">
<title>Isolation-induced ultrasonic vocalizations (USVs)</title>
<p id="Par37">On PND 13, the USVs emitted by each pup removed from the nest and placed into a Plexiglas arena were detected for 3 min by an ultrasound microphone (Avisoft Bioacoustics, Germany) sensitive to frequencies between 10 and 200 kHz. The USVs were analyzed quantitatively using Avisoft Recorder software (Version 5.1).</p>
</sec>
<sec id="Sec6">
<title>Three-chamber test</title>
<p id="Par38">The test was performed as previously described [<xref ref-type="bibr" rid="CR40">40</xref>]. The apparatus was a rectangular three-chamber box, with two lateral chambers (30 l × 35 w × 35 h cm) connected to a central chamber (15 l × 35 w × 35 h cm). Each lateral chamber contained a small Plexiglas cylindrical cage. At PND 35, each experimental rat was individually allowed to explore the three-chamber apparatus for 10 min, and then confined in the central compartment. An unfamiliar stimulus animal was confined in a cage located in one chamber of the apparatus, while the cage in the other chamber was left empty. Both doors to the side chambers were then opened, allowing the experimental animal to explore the apparatus for 10 min. The percent of time spent in social approach (sniffing the stimulus animal) were scored using the Observer 3.0 software (Noldus, The Netherlands).</p>
</sec>
<sec id="Sec7">
<title>Hole board test</title>
<p id="Par39">The apparatus was a gray square metal table (40 l × 40 w × 10 h cm) with 16 evenly spaced holes (4 cm in diameter), inserted in a Plexiglas arena (40 l × 40 w × 60 h cm). At PND 90, rats were individually placed in the apparatus and their behavior was observed for 5 min. Dipping behavior was scored by the number of times an animal inserted its head into a hole at least up to the eye level. Each session was recorded with a camera positioned above the apparatus for subsequent behavioral analysis performed using the Observer 3.0 software (Noldus Information Technology).</p>
</sec>
</sec>
<sec id="Sec8">
<title>Real-time quantitative PCR (RT-qPCR)</title>
<p id="Par40">Total mRNA of PfC, HPC, and Cb was isolated by TRI-Reagent (Sigma-Aldrich, Saint Louis, MO, USA) following the manufacturer’s instructions. For each brain tissue, the total amount of the mRNA was quantified by D30 BioPhotometer spectrophotometer (Eppendorf AG, Hamburg, Germany). The first-strand cDNA synthesis kit, adding oligo (dT) 0.2 μM and random primers 0.05 μg/μl was used to perform revers transcription of 1 μg mRNA to obtain cDNA (Promega, Promega Corporation, WI, USA). Reverse transcription was carried out with the following thermal protocol: + 25 °C for 10 min and + 72 °C for 65 min. Samples were stored at + 4 °C and then processed for mRNA encoding for S100B, glial fibrillary acidic protein (GFAP), Olig2, Iba1 (Bio-Fab laboratories, Rome, Italy), and the cluster of differentiation 11b (CD11b) (Bio-Rad, Hercules, CA, USA).</p>
<p id="Par41">To confirm pair’s primers efficiency, the amplification products from each primer pair were tested with the melting curve analyses. The amounts of the amplicons were normalized against TATA-box binding protein (TBP) and hypoxanthine guanine phosphoribosyl transferase (HPRT) used as reference genes (all primers sequences are listed in Table <xref ref-type="table" rid="Tab1">1</xref>). All amplifications were performed dissolving 500–800 nM primers and 75 ng cDNA in the iTaq Universal SYBR Green Supermix (Bio-Rad) using a CFX96 Touch thermocycler (Bio-Rad) according to the manufacturer’s instructions. The detection of the fluorescent signals was assessed at the end of the + 60 °C extension period. For each sequence of interest, three independent experiments were performed in triplicate. Data are expressed as the fold difference in mRNA expression (ΔΔCq) calculated according to the Pflaffl method.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Primer sequences and general conditions used to perform real-time qPCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>GENE</th><th colspan="2">Primer (5′ → 3′)</th><th>Annealing (°C)</th><th>Efficiency (%)</th><th>
<italic>R</italic>
<sup>2</sup>
</th></tr></thead><tbody><tr><td rowspan="2">S100B</td><td>Forward</td><td>TCAGGGAGAGAGGGTGACAA</td><td rowspan="2">60</td><td rowspan="2">94.6</td><td align="char" char="." rowspan="2">.998</td></tr><tr><td>Reverse</td><td>ACACTCCCCATCCCCATCTT</td></tr><tr><td rowspan="2">GFAP</td><td>Forward</td><td>CGGCTCTGAGAGAGATTCGC</td><td rowspan="2">60</td><td rowspan="2">105.0</td><td align="char" char="." rowspan="2">.989</td></tr><tr><td>Reverse</td><td>GCAAACTTGGACCGATACCA</td></tr><tr><td rowspan="2">Olig2</td><td>Forward</td><td>CCCGATGATCTTTTTCTGCC</td><td rowspan="2">60</td><td rowspan="2">98.8</td><td align="char" char="." rowspan="2">.990</td></tr><tr><td>Reverse</td><td>GCTTCTTATCTTTCTTGGTG</td></tr><tr><td rowspan="2">CD11b</td><td>Forward</td><td rowspan="2">N/A (Cod. qRnoCID0002800, Bio-Rad)</td><td rowspan="2">60</td><td rowspan="2">94.0</td><td align="char" char="." rowspan="2">.990</td></tr><tr><td>Reverse</td></tr><tr><td rowspan="2">Iba1</td><td>Forward</td><td>GTCCTTGAAGCGAATGCTGG</td><td rowspan="2">60</td><td rowspan="2">95.6</td><td align="char" char="." rowspan="2">.994</td></tr><tr><td>Reverse</td><td>CATTCTCAAGATGGCAGATC</td></tr><tr><td rowspan="2">HPRT</td><td>Forward</td><td>TCCCAGCGTCGTGATTAGTGA</td><td rowspan="2">60</td><td rowspan="2">98.3</td><td align="char" char="." rowspan="2">.992</td></tr><tr><td>Reverse</td><td>CCTTCATGACATCTCGAGCAAG</td></tr><tr><td rowspan="2">TBP</td><td>Forward</td><td>TGGGATTGTACCACAGCTCCA</td><td rowspan="2">60</td><td rowspan="2">99.7</td><td align="char" char="." rowspan="2">.995</td></tr><tr><td>Reverse</td><td>CTCATGATGACTGCAGCAAACC</td></tr></tbody></table><table-wrap-foot><p><italic>GFAP</italic> glial fibrillary acidic protein; <italic>CD11b</italic> cluster of differentiation 11b; <italic>HPRT</italic> hypoxanthine guanine phosphoribosyl transferase; <italic>TBP</italic> TATA-box binding protein</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec9">
<title>Western blot</title>
<p id="Par42">Total protein amount of PfC, HPC, and Cb was isolated and processed as previously described [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Brain tissues were mechanically lysed in ice-cold hypotonic lysis buffer containing 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM ethylenediamenetetraacetic acid (EDTA), 1% triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml aprotinin, and 0.1 mM leupeptin (all from Sigma-Aldrich), and then incubated for 40 min at + 4 °C. After centrifugation at 14000 rpm for 30 min, supernatants were collected and stored at − 80 °C. Protein concentration was calculated by Bradford assay to resolve an equal amount of proteins for each sample. Thirty micrograms were resolved through 12% acrylamide SDS-PAGE gel and then transferred onto nitrocellulose membranes with a trans-blot semi-dry transfer cell (Bio-Rad). From this step on, membranes were treated on an orbital shaker. Unspecific bound of the antibodies was avoided by incubating membranes for 1 h at room temperature in a blocking solution containing either 5% non-fat dry milk (Bio-Rad) or 5% bovine serum albumin (BSA, Sigma-Aldrich) in tris-buffered saline (TBS) (Corning, NY, USA) 0.1% tween 20 (TBS-T). Then, an overnight incubation with the proper primary antibodies against S100B, GFAP, Olig2, CD11b, or Iba1 was performed at + 4 °C (experimental conditions are reported in Table <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Experimental conditions used to perform western blot experiments</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Primary antibody</th><th>Brand/cat #</th><th>Dilution</th><th>Secondary antibody</th><th>Brand/cat #</th></tr></thead><tbody><tr><td rowspan="2">Rabbit α-S100B</td><td>Genetex</td><td>1:1000</td><td>HRP conjugated goat anti-rabbit IgG 1:10000</td><td>Jackson ImmunoResearch</td></tr><tr><td>GTX129573</td><td>5% BSA in TBS-T 0.1%</td><td>5% BSA in TBS-T 0.1%</td><td>111-035-045</td></tr><tr><td rowspan="2">Rabbit α-GFAP</td><td>Abcam</td><td>1:25000</td><td>HRP conjugated goat anti-rabbit IgG 1:10000</td><td>Jackson ImmunoResearch</td></tr><tr><td>ab7260</td><td>5% milk in TBS-T 0.1%</td><td>5% milk in TBS-T 0.1%</td><td>111-035-045</td></tr><tr><td rowspan="2">Rabbit α-Olig2</td><td>Santa Cruz</td><td>1:500</td><td>HRP conjugated goat anti-rabbit IgG 1: 10000</td><td>Jackson ImmunoResearch</td></tr><tr><td>sc-48817</td><td>5% milk in TBS-T 0.1%</td><td>5% milk in TBS-T 0.1%</td><td>111-035-045</td></tr><tr><td rowspan="2">Rabbit α-CD11b</td><td>Bioss</td><td>1:1000</td><td>HRP conjugated goat anti-rabbit IgG 1:10000</td><td>Jackson ImmunoResearch</td></tr><tr><td>bs-1014R</td><td>5% BSA in TBS-T 0.1%</td><td>5% BSA in TBS-T 0.1%</td><td>111-035-045</td></tr><tr><td rowspan="2">Rabbit α-Iba1</td><td>Abcam</td><td>1:1000</td><td>HRP conjugated goat anti-rabbit IgG 1:10000</td><td>Jackson ImmunoResearch</td></tr><tr><td>ab178846</td><td>5% milk in TBS-T 0.1%</td><td>5% milk in TBS-T 0.1%</td><td>111-035-045</td></tr><tr><td rowspan="2">Rabbit α-β-actin</td><td>Santa Cruz</td><td>1:1000</td><td>HRP conjugated goat anti-rabbit IgG 1:20000</td><td>Jackson ImmunoResearch</td></tr><tr><td>sc-1616R</td><td>5% milk in TBS-T 0.1%</td><td>5% milk in TBS-T 0.1%</td><td>111-035-045</td></tr></tbody></table><table-wrap-foot><p><italic>GFAP</italic> glial fibrillary acidic protein; <italic>CD11b</italic> cluster of differentiation 11b; <italic>MAP2</italic> microtubule associated protein; <italic>BSA</italic> bovine serum albumin; <italic>TBS-T</italic> tris buffered saline tween 20; <italic>HRP</italic> horseradish peroxidase</p></table-wrap-foot></table-wrap></p>
<p id="Par43">After removing the excess of antibody solution, the membranes were rinsed in TBS-T 0.05% and incubated for 1 h at room temperature with a specific secondary horseradish peroxidase (HRP)-conjugated antibody (Table <xref ref-type="table" rid="Tab2">2</xref>) to detect immunocomplexes by an enhanced chemiluminescence (ECL) kit (GE Healthcare Life Sciences, Milan, Italy). Immunocomplexes were visualized using a Chemidoc XRS+ and Image Lab software (Bio-Rad), and then quantified by ImageJ software. Values were normalized to those of β-actin.</p>
<p id="Par44">For each protein of interest, three independent experiments were performed in triplicate. Data are expressed as percentage of control.</p>
</sec>
<sec id="Sec10">
<title>Immunofluorescence</title>
<p id="Par45">Immunofluorescence was performed as previously described [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. The assay was performed on 12-μm-thick coronal slices of PfC, HPC, and Cb. Tissues were rinsed in phosphate-buffered saline (PBS) and post-fixed with 4% paraformaldehyde (PFA). After the blocking step lasting 90 min at room temperature in 1% BSA dissolved in PBS/0.25% triton X-100, sections were incubated overnight with the primary antibody recognizing GFAP, Olig2, or Iba1 at + 4 °C. Primary antibodies were diluted in 0.5% BSA in PBS/0.25% triton X-100. Tissues were rinsed in PBS and incubated for 2 h at room temperature with the proper secondary antibody. The staining of nuclei was performed with Hoechst (1:5000, Thermo Fisher Scientific, MA, USA). After rinses in PBS slices were mounted with Fluoromount aqueous mounting medium (Sigma-Aldrich). The experimental conditions are summarized in Table <xref ref-type="table" rid="Tab3">3</xref>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Experimental conditions used to perform immunofluorescence</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Primary antibody</th><th>Brand/cat #</th><th>Dilution</th><th>Secondary antibody</th><th>Brand/cat #</th></tr></thead><tbody><tr><td rowspan="2">Rabbit α-GFAP</td><td>Abcam</td><td>1:200</td><td rowspan="2">FITC conjugated goat anti-rabbit IgG (H + L) 1:200, 5% BSA in PBS/0.25% triton X-100</td><td>Jackson ImmunoResearch</td></tr><tr><td>ab7260</td><td>5% BSA in PBS/0.25% triton X-100</td><td>111-095-003</td></tr><tr><td rowspan="2">Rabbit α-Olig2</td><td>Santa Cruz</td><td>1:250</td><td rowspan="2">FITC conjugated goat anti-rabbit IgG (H + L) 1:200, 0.5% BSA in PBS/0.25% triton X-100</td><td>Jackson ImmunoResearch</td></tr><tr><td>sc-48817</td><td>0.5% BSA in PBS/0.25% triton X-100</td><td>111-095-003</td></tr><tr><td rowspan="2">Rabbit α-Iba1</td><td>Wako</td><td>1:1000</td><td rowspan="2">FITC conjugated goat anti-rabbit IgG (H + L) 1:200, 0.5% BSA in PBS/0.25% triton X-100</td><td>Jackson ImmunoResearch</td></tr><tr><td>019-19741</td><td>0.5% BSA in PBS/0.25% triton X-100</td><td>111-095-003</td></tr></tbody></table><table-wrap-foot><p><italic>GFAP</italic> glial fibrillary acidic protein; <italic>MAP2</italic> microtubule associated protein; <italic>BSA</italic> bovine serum albumin; <italic>FITC</italic> fluorescein isothiocyanate; <italic>PBS</italic> phosphate buffered saline</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec11">
<title>Cell count analysis</title>
<p id="Par46">Cells labeled with the different markers were quantified in 4 serial coronal 12 μm sections, spaced 48 μm apart, in each brain region for each animal. We used three rats per experimental group (<italic>N</italic> = 3 vehicle and <italic>N</italic> = 3 VPA) for each age, for a total of 18 rats. The brain regions analyzed were the PfC, the molecular layer (ML) and the granular cell layer (GL) of the Cb, the stratum radiatum of the Ammon’s horn 1 (CA1), CA2, CA3, and hilus of the dentate gyrus (DG) of the HPC. Nuclei were stained with Hoechst dye. Cells were identified as positive for a marker if they expressed immunoreactivity visually deemed to be above background. Images were captured using a × 20/0.50 magnification objective, and digitization was executed with a wide-field microscope (Eclipse E600; Nikon Instruments, Rome, Italy) connected to a QImaging camera with NIS-Elements BR 3.2 64-bit software. We used a 200 × 100 × 12 μm capture field of view to analyze the number of immunopositive cells within each field using the multi-point button of the Fiji Is Just ImageJ (FIJI) software. Cell count analyses, expressed as number of antibody positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> of tissue, were carried out by a blind observer.</p>
</sec>
<sec id="Sec12">
<title>Statistical analysis</title>
<p id="Par47">GraphPad Prism 6 software (GraphPad Software, San Diego, CA, USA) was used for the statistical analyses. Student’s <italic>t</italic> test was used to compare Veh and VPA groups. Data are presented as mean ± SEM. Differences between means were considered as significant at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="Sec13">
<title>Results</title>
<sec id="Sec14">
<title>Behavioral tests</title>
<p id="Par48">Animals prenatally exposed to VPA showed enduring impairments in the three core symptoms of autism. At infancy, VPA-exposed pups separated from the dam and siblings vocalized significantly less compared to Veh-exposed pups (<italic>t</italic> = 2.334; <italic>p</italic> &lt; 0.05; df = 8, Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). At adolescence, VPA-exposed rats showed decreased sociability in the three-chamber test, since they spent less time sniffing the stimulus animal compared to Veh-exposed animals (<italic>t</italic> = − 2.436; <italic>p</italic> &lt; 0.05; df = 8, Fig. <xref ref-type="fig" rid="Fig1">1</xref>c). At adulthood, VPA-exposed rats showed stereotypic behaviors in the hole board test, since they made more head dipping at PND 90 (<italic>t</italic> = − 2.781; <italic>p</italic> &lt; 0.05; df = 8, Fig. <xref ref-type="fig" rid="Fig1">1</xref>d).</p>
<p id="Par49">In their entirety, these results confirm that prenatal exposure to VPA causes the manifestation of autistic-like behaviors that persist from infancy to early adulthood.</p>
</sec>
<sec id="Sec15">
<title>Astrocytes in ASD model rats</title>
<p id="Par50">To investigate the effect of prenatal VPA exposure on astrocyte phenotype, we analyzed transcription and expression of the archetypal astroglial markers GFAP and the neurotrophin/Ca<sup>2+</sup> binding protein S100B. At PND 13, we observed a significant reduction of S100B mRNA in the HPC of VPA-exposed rats compared to control animals, with no significant modification in its protein expression (Fig. <xref ref-type="fig" rid="Fig2">2</xref>a, b). At the same age, we detected a significant increase of GFAP mRNA in the HPC of VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). No changes in GFAP protein were observed among all groups by western blot (Fig. <xref ref-type="fig" rid="Fig2">2</xref>d); however, immunofluorescence experiments revealed a significant increase of GFAP-positive cells in the PfC of VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig2">2</xref>e, f).<fig id="Fig2"><label>Fig. 2</label><caption><p>Effect of prenatal VPA exposure on astrocytes in infancy. Analysis of the neurotrophin S100B and the GFAP in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) infant rats (PND 13). Representation of the relative concentration of S100B (<bold>a</bold>) and GFAP (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for S100B (<bold>b</bold>) and GFAP (<bold>d</bold>) proteins, and densitometric analyses are normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of GFAP (green) staining in the PfCGL and MLof Cb, and CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of GFAP-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO2" xlink:href="13229_2018_254_Fig2_HTML"></graphic></fig></p>
<p id="Par51">At PND 35 rats showed higher levels of S100B mRNA in both PfC and HPC of VPA-exposed rats, with a significant reduction in the Cb (Fig. <xref ref-type="fig" rid="Fig3">3</xref>a). A decreased level of GFAP mRNA was found in the PfC and in the Cb of VPA animals compared to controls (Fig. <xref ref-type="fig" rid="Fig3">3</xref>c). No modifications of S100B levels were found at protein level (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b), whereas GFAP protein expression was higher in the PfC of VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig3">3</xref>d).The number of GFAP-positive cells was decreased in the GL of the Cb, and in the CA1 and DG hippocampal sub-regions, while a significant increase of GFAP-positive astrocytes was observed in the CA3 of VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig3">3</xref>e, f). Results obtained in adult rats demonstrate transcriptional modifications and some alterations in protein content. At PND 90, VPA-exposed animals showed higher levels of S100B mRNA in Cb and HPC (Fig. <xref ref-type="fig" rid="Fig4">4</xref>a). Conversely, GFAP mRNA was lower in the HPC and higher in the Cb of VPA-exposed rats compared to Veh animals (Fig. <xref ref-type="fig" rid="Fig4">4</xref>c). No changes in the protein expression of GFAP and S100B were detected (Fig. <xref ref-type="fig" rid="Fig4">4</xref>b, d). Finally, significantly higher number of GFAP-positive cells in the ML of the Cb and CA2 of the HPC of VPA-exposed rats was documented (Fig. <xref ref-type="fig" rid="Fig4">4</xref>e, f).<fig id="Fig3"><label>Fig. 3</label><caption><p>Effect of the prenatal VPA exposure on astrocytes in adolescence. Evaluation of the neurotrophin S100B and the cytoskeletal GFAP in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adolescent rats (PND 35). Representation of the relative concentration of S100B (<bold>a</bold>) and GFAP (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for S100B (<bold>b</bold>) and GFAP (<bold>d</bold>) proteins, and densitometric analyses normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of GFAP (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of GFAP-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO3" xlink:href="13229_2018_254_Fig3_HTML"></graphic></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Effect of the prenatal VPA exposure on astrocytes in adulthood. Evaluation of the neurotrophin S100B and the cytoskeletal GFAP in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adult rats (PND 90). Representation of the relative concentration of S100B (<bold>a</bold>) and GFAP (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for S100B (<bold>b</bold>) and GFAP (<bold>d</bold>) proteins, and densitometric analyses normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of GFAP (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of GFAP-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO4" xlink:href="13229_2018_254_Fig4_HTML"></graphic></fig></p>
<p id="Par52">In summary, prenatal exposure to VPA differentially affects astrocytes in different brain regions, and causes transcriptional modifications of S100B and GFAP, which are particularly evident in adolescent and adult rats, where modified GFAP expression is also observed.</p>
</sec>
<sec id="Sec16">
<title>Oligodendrocytes in ASD model rats</title>
<p id="Par53">We examined the effects of prenatal exposure to VPA on oligodendrocytes by testing Olig2, a transcriptional factor essential for oligodendrocyte development. Infant VPA-exposed rats showed higher levels of Olig2 mRNA in PfC and HPC, and a trend toward an increase of Olig2 protein expression (+ 76.77%) in PfC compared to age-matched control animals (Fig. <xref ref-type="fig" rid="Fig5">5</xref>a, b). No changes of Olig2-positive cells density were observed, except for the CA3 sub-region of the HPC where a significant decrease of their population was detected (Fig. <xref ref-type="fig" rid="Fig5">5</xref>c, d).<fig id="Fig5"><label>Fig. 5</label><caption><p>Effect of the prenatal VPA exposure on oligodendrocytes in infancy. Evaluation of the transcription factor Olig2 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) infant rats (PND 13). Representation of the relative concentration of Olig2 (<bold>a</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for Olig2 protein and densitometric analyses normalized to β-actin used as loading control (<bold>b</bold>). Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Olig2 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>c</bold>). The images have been analyzed by counting the number of Olig2-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>d</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO5" xlink:href="13229_2018_254_Fig5_HTML"></graphic></fig></p>
<p id="Par54">The RT-qPCR analysis revealed a significant increase of Olig2 in the PfC of VPA-exposed rats at PND 35, with a decrease of this transcription factor in the HPC of the same animals (Fig. <xref ref-type="fig" rid="Fig6">6</xref>a). These modifications were evident also at a protein level. In adolescent VPA-exposed rats, we observed a statistically significant increase of Olig2 protein expression in the PfC, a significant decrease in the Cb, and a trend toward a decrease in the HPC (− 27.24%) (Fig. <xref ref-type="fig" rid="Fig6">6</xref>b). A more detailed analysis of the brain areas revealed subtler modifications in Olig2-positive cells distribution. In particular, in VPA-exposed rats we observed a significant increase in the number of Olig2-positive cells in the GL of the Cb and in the DG of the HPC, and a statistically significant reduction of Olig2-positive cells in the CA1 and CA2 of the same animals (Fig. <xref ref-type="fig" rid="Fig6">6</xref>c, d). In adult (PND 90) rats prenatally exposed to VPA, a significant decrease of Olig2 mRNA was observed solely in the HPC (Fig. <xref ref-type="fig" rid="Fig7">7</xref>a). On the contrary, the Olig2 protein was increased in the HPC of these animals (Fig. <xref ref-type="fig" rid="Fig7">7</xref>b). The VPA-exposed rats also showed more Olig2-positive cells in the ML of the Cb and in the CA1 (Fig. <xref ref-type="fig" rid="Fig7">7</xref>c, d).<fig id="Fig6"><label>Fig. 6</label><caption><p>Effect of the prenatal VPA exposure on oligodendrocytes in adolescence. Evaluation of the transcription factor Olig2 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adolescent rats (PND 35). Representation of the relative concentration of Olig2 (<bold>a</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for Olig2 protein and densitometric analyses normalized to β-actin used as loading control (<bold>b</bold>). Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Olig2 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>c</bold>). The images have been analyzed by counting the number of Olig2-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>d</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO6" xlink:href="13229_2018_254_Fig6_HTML"></graphic></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>Effect of the prenatal VPA exposure on oligodendrocytes in adulthood. Evaluation of the transcription factor Olig2 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adult rats (PND 90). Representation of the relative concentration of Olig2 (<bold>a</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for Olig2 protein and densitometric analyses normalized to β-actin used as loading control (<bold>b</bold>). Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Olig2 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>c</bold>). The images have been analyzed by counting the number of Olig2-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup>(scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>d</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO7" xlink:href="13229_2018_254_Fig7_HTML"></graphic></fig></p>
<p id="Par55">Collectively, these results demonstrate that the prenatal exposure to VPA modifies oligodendrocytes at both the transcriptional and translational levels, and that these changes occur mainly in the PfC and in the HPC. Of note, these alterations are particularly evident during adolescence, but seem to be compensated in adulthood.</p>
</sec>
<sec id="Sec17">
<title>Microglia in ASD model rats</title>
<p id="Par56">To characterize microglia in this rat model of ASD, we analyzed transcription and expression of CD11b, a marker of microglia activation, and Iba1, a Ca<sup>2+</sup>-binding protein constitutively expressed by both surveillant and activated microglia. In VPA-exposed rats at PND 13, we observed a significant increase of CD11b mRNA in PfC and HPC, and no substantial change in the protein expression except for a trend toward an increase of this marker in PfC (+ 54.36%) (Fig. <xref ref-type="fig" rid="Fig8">8</xref>a, b). At the same age, we detected a significant increase of Iba1 mRNA in the Cb of VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig8">8</xref>c). We also found a significant increase in the number of Iba-positive cells in the ML of the Cb of VPA-exposed rats with a significant decrease in the CA3 of the same animals (Fig. <xref ref-type="fig" rid="Fig8">8</xref>e, f).<fig id="Fig8"><label>Fig. 8</label><caption><p>Effect of the prenatal VPA exposure on microglia in infancy. Evaluation of the cluster of differentiation 11b (CD11b) and Iba1 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) infant rats (PND 13). Representation of the relative concentration of CD11b (<bold>a</bold>) and Iba1 (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for CD11b (<bold>b</bold>) and Iba1 (<bold>d</bold>) proteins, and densitometric analyses normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Iba1 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of Iba1-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO8" xlink:href="13229_2018_254_Fig8_HTML"></graphic></fig></p>
<p id="Par57">Adolescent (PND 35) rats displayed more pronounced modifications. A significant increase of both transcription and expression of CD11b in the PfC of VPA-exposed animals compared to control rats was detected (Fig. <xref ref-type="fig" rid="Fig9">9</xref>a, b). Moreover, a significant increase of Iba1 mRNA was found in the PfC of VPA-exposed rats, whereas, in the same animals, we observed reduced transcription in the HPC (Fig. <xref ref-type="fig" rid="Fig9">9</xref>c). No changes of protein expression of Iba1 were observed (Fig. <xref ref-type="fig" rid="Fig9">9</xref>d). The number of Iba1-positive cells increased in the GL of the Cb and in the CA1 of adolescent (PND 35) VPA-exposed rats (Fig. <xref ref-type="fig" rid="Fig9">9</xref>e, f).<fig id="Fig9"><label>Fig. 9</label><caption><p>Effect of the prenatal VPA exposure on microglia in adolescence. Evaluation of the cluster of differentiation 11b (CD11b) and Iba1 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adolescent rats (PND 35). Representation of the relative concentration of CD11b (<bold>a</bold>) and Iba1 (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for CD11b (<bold>b</bold>) and Iba1 (<bold>d</bold>) proteins, and densitometric analyses normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Iba1 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of Iba1-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO9" xlink:href="13229_2018_254_Fig9_HTML"></graphic></fig></p>
<p id="Par58">In adult rats (PND 90), no modifications of CD11b and Iba1 protein transcription and expression was observed, except for a trend toward an increase of CD11b expression in PfC (+ 47.04%) and Cb (+ 41.26%), and a significant decrease of Iba1 mRNA in the HPC of the same animals (Fig. <xref ref-type="fig" rid="Fig10">10</xref>a–d). At PND 90, the number of Iba1-positive cells was significantly reduced in PfC, CA1, and CA2 of rats prenatally exposed to VPA, while more Iba1-positive cells were detected in the GL of the Cb of the same animals (Fig. <xref ref-type="fig" rid="Fig10">10</xref>e, f).<fig id="Fig10"><label>Fig. 10</label><caption><p>Effect of the prenatal exposure to VPA on microglia in adulthood. Evaluation of the cluster of differentiation 11b (CD11b) and Iba1 in the PfC, Cb, and HPC of healthy- (open bars, Veh) and autistic-like (black bars, VPA) adult rats (PND 90). Representation of the relative concentration of CD11b (<bold>a</bold>) and Iba1 (<bold>c</bold>) in VPA animals compared to control (Veh), normalized to both TBP and HPRT (ΔΔCq; <italic>N</italic> = 3, in triplicate). Representative western blots for CD11b (<bold>b</bold>) and Iba1 (<bold>d</bold>) proteins, and densitometric analyses normalized to β-actin used as loading control. Results are expressed as percentage of control (Veh) (<italic>N</italic> = 3, in triplicate). Representative fluorescence micrographs of Iba1 (green) staining in the PfC, GL and ML of Cb, and stratum radiatum of CA1, CA2, CA3, and the hilus of the DG of the HPC. Nuclei were stained with Hoechst (blue) (<bold>e</bold>). The images have been analyzed by counting the number of Iba1-positive cells in 2.4 × 10<sup>5</sup> μm<sup>3</sup> (scale bar 50 μm; <italic>N</italic> = 3, 4 times) (<bold>f</bold>). All data are presented as means ± SEM. Statistical analysis was performed by <italic>t</italic> test (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 vs Veh group)</p></caption><graphic id="MO10" xlink:href="13229_2018_254_Fig10_HTML"></graphic></fig></p>
<p id="Par59">Taken together, these results indicate that the prenatal VPA exposure modifies microglia and that these changes occur mainly in the PfC and in the HPC. Moreover, we observed that the prenatal VPA exposure switches microglial phenotypes from resting to activated in infant and adolescent rats while this phenomenon is somewhat mitigated in adulthood.</p>
</sec>
</sec>
<sec id="Sec18">
<title>Discussion</title>
<p id="Par60">All three types of neuroglia are critically important for normal development of the CNS and for formation of neuronal ensembles. Astrocytes assist synaptogenesis [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], while astrocytes together with microglia shape neuronal networks through synaptic pruning and removal of redundant synaptic contacts [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR47">47</xref>]. Functional insufficiency of neuroglia leads to neurodevelopmental pathologies [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The role of neuroglial components in ASD has received much attention recently, when several lines of evidence have demonstrated glia-specific alterations in animal models of ASD as well as in patients suffering from this disorder (for recent reviews see [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]). The transcriptome analysis of the brains of ASD patients identified significant association of the pathology with genes linked to reactive gliosis and neuroinflammation [<xref ref-type="bibr" rid="CR50">50</xref>]. Increased expression of astroglia-specific proteins aquaporin-4 and connexin43 has been found in the autistic human tissue [<xref ref-type="bibr" rid="CR51">51</xref>]; increase in GFAP expression and astroglial hypertrophy was also observed with cerebellum demonstrating most prominent changes [<xref ref-type="bibr" rid="CR52">52</xref>]. Microglial activation and increase in pro-inflammatory factors were other characteristic features of ASD brain tissue [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref>].</p>
<p id="Par61">These findings support the notion of glia-related pathological developments that may exacerbate or even drive ASD evolution. Indeed, the autistic brain is affected already at the early developmental stages, when loss of function of microglia and astrocytes can affect formation of synaptically connected neuronal networks. Equally important could be the contribution of oligodendrocytes, which shape the brain connectome. Expression of specific markers associated with cells of oligodendroglial lineage (including for example oligodendrocyte transcription factor 1/2 or myelin basic protein) is increased in the cerebella of autistic patients [<xref ref-type="bibr" rid="CR55">55</xref>]. The single nucleotide polymorphisms of the central oligodendroglial differentiation regulator gene DUSP15 were identified in the brains of ASD patients [<xref ref-type="bibr" rid="CR56">56</xref>], while many components of a molecular network associated with ASD are specifically enriched in oligodendroglia and white matter [<xref ref-type="bibr" rid="CR57">57</xref>]. Changes in oligodendroglia and hence changes in white matter may be linked to a rather characteristic ASD-associated increase in the brain size (see for examples [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]).</p>
<p id="Par62">Astroglial as well as microglial abnormalities have been detected in animal models of several types of ASD associated with expression of pathologically modified genes; these include the Rett syndrome, fragile X syndrome, and tuberous sclerosis. In the Rett syndrome that arises from loss-of-function mutations in the X-linked MeCP2 encoding methyl-CpG-binding protein 2, the glial pathological phenotype has been clearly revealed. Microglial cells lacking MeCP2 triggered excitotoxicity through excessive release of glutamate [<xref ref-type="bibr" rid="CR60">60</xref>]; whereas MeCP2-deficient astrocytes lost their ability to support neuronal growth and dendritic ramifications in vitro [<xref ref-type="bibr" rid="CR61">61</xref>]. In the fragile X syndrome (which results from the loss of Fmr1 gene function), increased astroglial reactivity has been observed (in mice with genetic deletion of Fmr1 gene) [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
<p id="Par63">To summarize, the gliopathology in the ASD context is mainly represented by glial reactivity, which further highlights the contribution of neuroinflammation with both processes apparently having pathological significance. In this context, we asked ourselves whether the same reactive changes are pronounced in a rodent model of ASD resulting from in utero exposure to VPA, a widely used antiepileptic drug. The use of VPA has clinical significance as indeed VPA treatment during pregnancy has been related with a higher risk of ASD in the exposed children [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Despite this evidence, recent epidemiological studies show that the public awareness of such an association is still limited [<xref ref-type="bibr" rid="CR63">63</xref>].</p>
<p id="Par64">Rodents prenatally exposed to VPA are widely used as a preclinical model of ASD [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. The VPA-treated animals display several ASD-like symptoms in the course of development. These animals show impairment of the communicative capabilities, alteration of the social repertoire, stereotypical behavior, and anxiety [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. In particular, in line with previous studies [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>], we found that the infant male offspring born from VPA-treated rats exhibit reduced ability to interact with their mothers, since they emit less ultrasonic vocalizations when isolated from their mothers and siblings. This feature is accompanied by the inability of VPA-exposed pups to recognize familiar from unfamiliar odors, this being an early sign of the impairment in social recognition [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. All these aspects negatively affect the social postnatal development of the VPA-exposed offspring and persist through adolescence and adulthood [<xref ref-type="bibr" rid="CR40">40</xref>]. Indeed, VPA-exposed rats showed altered sociability in the three chamber test and increased stereotypic behavior in the hole board test. Our results are in agreement with those obtained by other researchers showing that a single injection of VPA to pregnant rats [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>] or mice [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR72">72</xref>] on gestational day 12.5 yielded offspring with a behavioral pattern strikingly similar to that observed in autism. Beside behavioral alterations, rats exposed to VPA in utero demonstrate molecular and metabolic abnormalities. Very recent experiments demonstrated that VPA exposure impairs repair of DNA damage [<xref ref-type="bibr" rid="CR41">41</xref>], modifies cholesterol/isoprenoid metabolism, and reduces the number of oligodendrocytes leading to lower myelin and cholesterol levels in the HPC of adolescent VPA-exposed rats [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
</sec>
<sec id="Sec19">
<title>Conclusions</title>
<p id="Par65">Here, we extend this scenario by showing that prenatal VPA exposure induces autistic-like behaviors and does affect neuroglia. Modifications identified are brain region- and age-dependent. The changes in glia which we observed in VPA-exposed rats have been rather modest and occurred mostly at young ages; moreover, the changes were quite heterogeneous as they differ between brain regions, and often we have not seen obvious correlation between expression of mRNA and respective protein. In line with previous findings [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR71">71</xref>], some hints for astrogliotic response were found in young animals, in which the density of GFAP-positive astrocytes has increased in the cortical regions. This increase went in parallel with elevated GFAP mRNA, without however changes in protein content. In adult rats, the number of GFAP-positive astrocytes was increased in CA3 but decreased in CA1 region and in cerebellum. Finally, in the mature rats, numbers of GFAP-positive cells were increased in Cb and CA2 hippocampal area, with no changes in expression of GFAP and S100B at a protein level. At the same time, the changes in expression of neuroglial markers seem to be rather mild, with neuroinflammatory phenotype being present mainly in young ages and being ameliorated in adulthood.</p>
<p id="Par66">All in all, the results we obtained in VPA-exposed rats are heterogeneous and intricate and reflect the complexity of the molecular and cellular mechanisms underlying ASD. Indeed, autism is a complex disease, whose clinic features are multifaceted and intricate like equally complex and subtle should be the molecular changes causing these phenotypes.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ASD</term>
<def>
<p id="Par5">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>BSA</term>
<def>
<p id="Par6">Bovine serum albumin</p>
</def>
</def-item>
<def-item>
<term>Cb</term>
<def>
<p id="Par7">Cerebellum</p>
</def>
</def-item>
<def-item>
<term>CD11b</term>
<def>
<p id="Par8">Cluster of differentiation 11b</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p id="Par9">Central nervous system</p>
</def>
</def-item>
<def-item>
<term>DG</term>
<def>
<p id="Par10">Dentate gyrus</p>
</def>
</def-item>
<def-item>
<term>ECL</term>
<def>
<p id="Par11">Enhanced chemiluminescence</p>
</def>
</def-item>
<def-item>
<term>EDTA</term>
<def>
<p id="Par12">Ethylenediaminetetraacetic acid</p>
</def>
</def-item>
<def-item>
<term>GD</term>
<def>
<p id="Par13">Gestational day</p>
</def>
</def-item>
<def-item>
<term>GFAP</term>
<def>
<p id="Par14">Glial fibrillary acidic protein</p>
</def>
</def-item>
<def-item>
<term>GL</term>
<def>
<p id="Par15">Granular layer</p>
</def>
</def-item>
<def-item>
<term>HPC</term>
<def>
<p id="Par16">Hippocampus</p>
</def>
</def-item>
<def-item>
<term>HPRT</term>
<def>
<p id="Par17">Hypoxanthine guanine phosphoribosyl transferase</p>
</def>
</def-item>
<def-item>
<term>HRP</term>
<def>
<p id="Par18">Secondary horseradish peroxidase</p>
</def>
</def-item>
<def-item>
<term>ML</term>
<def>
<p id="Par19">Molecular layer</p>
</def>
</def-item>
<def-item>
<term>PBS</term>
<def>
<p id="Par20">Phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term>PFA</term>
<def>
<p id="Par21">Paraformaldehyde</p>
</def>
</def-item>
<def-item>
<term>PfC</term>
<def>
<p id="Par22">Prefrontal cortex</p>
</def>
</def-item>
<def-item>
<term>PMSF</term>
<def>
<p id="Par23">Phenylmethylsulfonyl fluoride</p>
</def>
</def-item>
<def-item>
<term>PND</term>
<def>
<p id="Par24">Postnatal day</p>
</def>
</def-item>
<def-item>
<term>RT-qPCR</term>
<def>
<p id="Par25">Real-time quantitative PCR</p>
</def>
</def-item>
<def-item>
<term>TBP</term>
<def>
<p id="Par26">TATA-box binding protein</p>
</def>
</def-item>
<def-item>
<term>TBS-T</term>
<def>
<p id="Par27">Tris-buffered saline 0.1% tween 20</p>
</def>
</def-item>
<def-item>
<term>USVs</term>
<def>
<p id="Par28">Isolation-induced ultrasonic vocalizations</p>
</def>
</def-item>
<def-item>
<term>Veh</term>
<def>
<p id="Par29">Saline</p>
</def>
</def-item>
<def-item>
<term>VPA</term>
<def>
<p id="Par30">Valproic acid</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<sec id="FPar1">
<title>Funding</title>
<p id="Par67">This work was supported by SAPIENZA University of Rome grant n.MA116154CD981DAE (CS), Marie Curie Career Reintegration Grant PCIG09-GA-2011-293589 (VT) and the Jerome Lejeune Foundation Research grant #1674 (VT).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par68">The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>MRB, RF, DI, and CS performed most of the molecular experiments and analyzed the data. MS, SS, and VT treated and housed the animals, and performed the behavioral tasks. VT, LS, AV, and CS supervised the experiments and discussed the results. MRB, RF, VT, AV, and CS wrote the manuscript. All authors contributed to and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval</title>
<p>All procedures involving animals were performed in accordance with the guidelines of the Italian Ministry of Health (D.L. 26/2014) and with the European Parliament directive 2010/63/EU.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillott</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Standen</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Levels of anxiety and sources of stress in adults with autism</article-title>
<source/>J Intellect Disabil
          <year>2007</year>
<volume>11</volume>
<issue>4</issue>
<fpage>359</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.1177/1744629507083585</pub-id>
<pub-id pub-id-type="pmid">18029412</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Autism</article-title>
<source/>Lancet
          <year>2014</year>
<volume>383</volume>
<issue>9920</issue>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Bilder</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Zahorodny</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pettygrove</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Durkin</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>RT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the autism and developmental disabilities monitoring network</article-title>
<source/>J Dev BehavPediatr
          <year>2016</year>
<volume>37</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dietert</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Dietert</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dewitt</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Environmental risk factors for autism</article-title>
<source/>Emerg Health Threats J
          <year>2011</year>
<volume>4</volume>
<fpage>7111</fpage>
<pub-id pub-id-type="doi">10.3402/ehtj.v4i0.7111</pub-id>
<pub-id pub-id-type="pmid">24149029</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kini</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Adab</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vinten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fryer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clayton-Smith</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Liverpool and Manchester neurodevelopmental study group. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes</article-title>
<source/>Arch Dis Child Fetal Neonatal
          <year>2006</year>
<volume>91</volume>
<fpage>F90</fpage>
<lpage>F95</lpage>
<pub-id pub-id-type="doi">10.1136/adc.2004.067421</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozma</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature</article-title>
<source/>Am J Med Genet
          <year>2001</year>
<volume>98</volume>
<issue>2</issue>
<fpage>168</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;168::AID-AJMG1026&gt;3.0.CO;2-O</pub-id>
<pub-id pub-id-type="pmid">11223853</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Hersh</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>A male with fetal valproate syndrome and autism</article-title>
<source/>Dev Med Child Neurol
          <year>1997</year>
<volume>39</volume>
<issue>9</issue>
<fpage>632</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1997.tb07500.x</pub-id>
<pub-id pub-id-type="pmid">9344057</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>G</given-names>
</name>
<name>
<surname>King</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hersh</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Fetal valproate syndrome and autism: additional evidence of an association</article-title>
<source/>Dev Med Child Neurol
          <year>2001</year>
<volume>43</volume>
<issue>3</issue>
<fpage>202</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2001.tb00188.x</pub-id>
<pub-id pub-id-type="pmid">11263692</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roullet</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>In utero exposure to valproic acid and autism--a current review of clinical and animal studies</article-title>
<source/>Neurotoxicol Teratol
          <year>2013</year>
<volume>36</volume>
<fpage>47</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.ntt.2013.01.004</pub-id>
<pub-id pub-id-type="pmid">23395807</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Servadio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Modeling autism-relevant behavioral phenotypes in rats and mice: do ‘autistic’ rodents exist?</article-title>
<source/>Behav Pharmacol
          <year>2015</year>
<volume>26</volume>
<issue>6</issue>
<fpage>522</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1097/FBP.0000000000000163</pub-id>
<pub-id pub-id-type="pmid">26226143</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fahnestock</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The valproic acid-induced rodent model of autism</article-title>
<source/>Exp Neurol
          <year>2018</year>
<volume>299</volume>
<fpage>217</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.04.017</pub-id>
<pub-id pub-id-type="pmid">28472621</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">Verkhratsky A, Butt AM. Glial physiology and pathophysiology. 1st ed: Wiley-Blackwell; 2013. Hoboken (NJ), USA</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Bordey</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The astrocyte odyssey</article-title>
<source/>Prog Neurobiol
          <year>2008</year>
<volume>86</volume>
<issue>4</issue>
<fpage>342</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="pmid">18948166</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Heneka</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Montana</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Oliet</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Schousboe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haydon</surname>
<given-names>PG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glial cells in (patho)physiology</article-title>
<source/>J Neurochem
          <year>2012</year>
<volume>121</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07664.x</pub-id>
<pub-id pub-id-type="pmid">22251135</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<mixed-citation publication-type="other">Verkhratsky A, Nedergaard M. The homeostatic astroglia emerges from evolutionary specialization of neural cells. Philos Trans R Soc Lond B Biol Sci. 2016;371(1700). 10.1098/rstb.2015.0428.</mixed-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Physiology of astroglia</article-title>
<source/>Physiol Rev
          <year>2018</year>
<volume>98</volume>
<fpage>239</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00042.2016</pub-id>
<pub-id pub-id-type="pmid">29351512</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eroglu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Regulation of synaptic connectivity by glia</article-title>
<source/>Nature
          <year>2010</year>
<volume>468</volume>
<fpage>223</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1038/nature09612</pub-id>
<pub-id pub-id-type="pmid">21068831</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Astroglial cradle in the life of the synapse</article-title>
<source/>Philos Trans R Soc Lond Ser B Biol Sci
          <year>2014</year>
<volume>369</volume>
<fpage>20130595</fpage>
<pub-id pub-id-type="doi">10.1098/rstb.2013.0595</pub-id>
<pub-id pub-id-type="pmid">25225089</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zorec</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Horvat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vardjan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Memory formation shaped by astroglia</article-title>
<source/>Front Integr Neurosci
          <year>2015</year>
<volume>9</volume>
<fpage>56</fpage>
<pub-id pub-id-type="doi">10.3389/fnint.2015.00056</pub-id>
<pub-id pub-id-type="pmid">26635551</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nave</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Myelination and support of axonal integrity by glia</article-title>
<source/>Nature
          <year>2010</year>
<volume>468</volume>
<issue>7321</issue>
<fpage>244</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1038/nature09614</pub-id>
<pub-id pub-id-type="pmid">21068833</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bessis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Béchade</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roumier</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microglial control of neuronal death and synaptic properties</article-title>
<source/>Glia
          <year>2007</year>
<volume>55</volume>
<issue>3</issue>
<fpage>233</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1002/glia.20459</pub-id>
<pub-id pub-id-type="pmid">17106878</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wake</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Moorhouse</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Jinno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kohsaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nabekura</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals</article-title>
<source/>J Neurosci
          <year>2009</year>
<volume>29</volume>
<issue>13</issue>
<fpage>3974</fpage>
<lpage>3980</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4363-08.2009</pub-id>
<pub-id pub-id-type="pmid">19339593</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kettenmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hanisch</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Physiology of microglia</article-title>
<source/>Physiol Rev
          <year>2011</year>
<volume>91</volume>
<fpage>461</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00011.2010</pub-id>
<pub-id pub-id-type="pmid">21527731</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salter</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Microglia emerge as central players in brain disease</article-title>
<source/>Nat Med
          <year>2017</year>
<volume>23</volume>
<issue>9</issue>
<fpage>1018</fpage>
<lpage>1027</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4397</pub-id>
<pub-id pub-id-type="pmid">28886007</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pekny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pekna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Messing</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steinhauser</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Astrocytes: a central element in neurological diseases</article-title>
<source/>Acta Neuropathol
          <year>2016</year>
<volume>131</volume>
<fpage>323</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-015-1513-1</pub-id>
<pub-id pub-id-type="pmid">26671410</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Diversity of astroglial responses across human neurodegenerative disorders and brain aging</article-title>
<source/>Brain Pathol
          <year>2017</year>
<volume>27</volume>
<fpage>645</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1111/bpa.12538</pub-id>
<pub-id pub-id-type="pmid">28804999</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zorec</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Stratification of astrocytes in healthy and diseased brain</article-title>
<source/>Brain Pathol
          <year>2017</year>
<volume>27</volume>
<fpage>629</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1111/bpa.12537</pub-id>
<pub-id pub-id-type="pmid">28805002</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Prinz</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microglia as modulators of cognition and neuropsychiatric disorders</article-title>
<source/>Glia
          <year>2013</year>
<volume>61</volume>
<issue>1</issue>
<fpage>62</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22372</pub-id>
<pub-id pub-id-type="pmid">22740320</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scuderi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stecca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Valenza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ratano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bronzuoli</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bartoli</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease</article-title>
<source/>Cell Death Dis
          <year>2014</year>
<volume>5</volume>
<fpage>e1419</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2014.376</pub-id>
<pub-id pub-id-type="pmid">25210802</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scuderi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bronzuoli</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Facchinetti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Broad</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects</article-title>
<source/>Transl Psychiatry
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>32</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-017-0076-4</pub-id>
<pub-id pub-id-type="pmid">29382825</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders</article-title>
<source/>Neurobiol Dis
          <year>2016</year>
<volume>85</volume>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.03.025</pub-id>
<pub-id pub-id-type="pmid">25843667</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zorec</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Astroglia dynamics in ageing and Alzheimer’s disease</article-title>
<source/>Curr Opin Pharmacol
          <year>2016</year>
<volume>26</volume>
<fpage>74</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1016/j.coph.2015.09.011</pub-id>
<pub-id pub-id-type="pmid">26515274</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zorec</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vardjan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Astrocytic face of Alzheimer’s disease</article-title>
<source/>Behav Brain Res
          <year>2017</year>
<volume>322</volume>
<issue>Pt B</issue>
<fpage>250</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2016.05.021</pub-id>
<pub-id pub-id-type="pmid">27173426</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronzuoli</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Facchinetti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Steardo</surname>
<given-names>L</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Romano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stecca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Passarella</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence</article-title>
<source/>Oxid Med Cell Longev
          <year>2018</year>
<volume>2018</volume>
<fpage>4720532</fpage>
<pub-id pub-id-type="doi">10.1155/2018/4720532</pub-id>
<pub-id pub-id-type="pmid">29576849</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monzón</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hernández</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Garcés</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sarasa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Badiola</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Glial alterations in human prion diseases: a correlative study of astroglia, reactive microglia, protein deposition, and neuropathological lesions</article-title>
<source/>Medicine (Baltimore)
          <year>2018</year>
<volume>97</volume>
<issue>15</issue>
<fpage>e0320</fpage>
<pub-id pub-id-type="doi">10.1097/MD.0000000000010320</pub-id>
<pub-id pub-id-type="pmid">29642165</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villadiego</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Labrador-Garrido</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Leal-Lasarte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Genst</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model</article-title>
<source/>Glia
          <year>2018</year>
<volume>66</volume>
<issue>1</issue>
<fpage>191</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1002/glia.23237</pub-id>
<pub-id pub-id-type="pmid">29024008</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dichter</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Felder</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Rittenberg</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sasson</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Bodfish</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Reward circuitry function in autism spectrum disorders</article-title>
<source/>Soc Cogn Affect Neurosci
          <year>2012</year>
<volume>7</volume>
<issue>2</issue>
<fpage>160</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1093/scan/nsq095</pub-id>
<pub-id pub-id-type="pmid">21148176</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donovan</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Basson</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>The neuroanatomy of autism—a developmental perspective</article-title>
<source/>J Anat
          <year>2017</year>
<volume>230</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1111/joa.12542</pub-id>
<pub-id pub-id-type="pmid">27620360</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Distler</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Halbedl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Verpelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bockmann</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteomic analysis of post-synaptic density fractions from shank3 mutant mice reveals brain region specific changes relevant to autism spectrum disorder</article-title>
<source/>Front Mol Neurosci
          <year>2017</year>
<volume>10</volume>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00026</pub-id>
<pub-id pub-id-type="pmid">28261056</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Servadio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Melancia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Manduca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>di Masi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schiavi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cartocci</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid</article-title>
<source/>Transl Psychiatry
          <year>2016</year>
<volume>6</volume>
<issue>9</issue>
<fpage>e902</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.182</pub-id>
<pub-id pub-id-type="pmid">27676443</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Servadio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manduca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melancia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Leboffe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schiavi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Campolongo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2018</year>
<volume>28</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2017.11.014</pub-id>
<pub-id pub-id-type="pmid">29174949</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder</article-title>
<source/>J Neurochem
          <year>2013</year>
<volume>124</volume>
<issue>6</issue>
<fpage>832</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12147</pub-id>
<pub-id pub-id-type="pmid">23311691</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melancia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schiavi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Servadio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cartocci</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Campolongo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Palmery</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling</article-title>
<source/>Br J Pharmacol
          <year>2018</year>
<volume>175</volume>
<issue>18</issue>
<fpage>3699</fpage>
<lpage>3712</lpage>
<pub-id pub-id-type="doi">10.1111/bph.14435</pub-id>
<pub-id pub-id-type="pmid">29968249</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartocci</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Catallo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tempestilli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Segatto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pfrieger</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Bronzuoli</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders</article-title>
<source/>Neuroscience
          <year>2018</year>
<volume>372</volume>
<fpage>27</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.12.053</pub-id>
<pub-id pub-id-type="pmid">29309878</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paolicelli</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pagani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scianni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Panzanelli</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic pruning by microglia is necessary for normal brain development</article-title>
<source/>Science
          <year>2011</year>
<volume>333</volume>
<fpage>1456</fpage>
<lpage>1458</lpage>
<pub-id pub-id-type="doi">10.1126/science.1202529</pub-id>
<pub-id pub-id-type="pmid">21778362</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremblay</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sierra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wake</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bessis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nimmerjahn</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of microglia in the healthy brain</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<fpage>16064</fpage>
<lpage>16069</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4158-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072657</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kettenmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microglia: new roles for the synaptic stripper</article-title>
<source/>Neuron
          <year>2013</year>
<volume>77</volume>
<fpage>10</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.023</pub-id>
<pub-id pub-id-type="pmid">23312512</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeidan-Chulia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Malinovskaya</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>The glial perspective of autism spectrum disorders</article-title>
<source/>Neurosci Biobehav Rev
          <year>2014</year>
<volume>38</volume>
<fpage>160</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.11.008</pub-id>
<pub-id pub-id-type="pmid">24300694</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pucci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bezzi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Astrocytes and microglia and their potential link with autism spectrum disorders</article-title>
<source/>Front Cell Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>21</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00021</pub-id>
<pub-id pub-id-type="pmid">26903806</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Folsom</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Reutiman</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism</article-title>
<source/>Synapse
          <year>2008</year>
<volume>62</volume>
<fpage>501</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="doi">10.1002/syn.20519</pub-id>
<pub-id pub-id-type="pmid">18435417</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vargas</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Nascimbene</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Neuroglial activation and neuroinflammation in the brain of patients with autism</article-title>
<source/>Ann Neurol
          <year>2005</year>
<volume>57</volume>
<fpage>67</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1002/ana.20315</pub-id>
<pub-id pub-id-type="pmid">15546155</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmonson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ziats</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Rennert</surname>
<given-names>OM</given-names>
</name>
</person-group>
<article-title>Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum</article-title>
<source/>Mol Autism
          <year>2014</year>
<volume>5</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-3</pub-id>
<pub-id pub-id-type="pmid">24410870</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tetreault</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Hakeem</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Allman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglia in the cerebralcortex in autism</article-title>
<source/>J Autism Dev Disord
          <year>2012</year>
<volume>42</volume>
<fpage>2569</fpage>
<lpage>2584</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-012-1513-0</pub-id>
<pub-id pub-id-type="pmid">22466688</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeidan-Chulia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Casanova</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Casanova</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Up-regulation of oligodendrocyte lineage markers in the cerebellum of autistic patients: evidence from network analysis of gene expression</article-title>
<source/>Mol Neurobiol
          <year>2016</year>
<volume>53</volume>
<fpage>4019</fpage>
<lpage>4025</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-015-9351-7</pub-id>
<pub-id pub-id-type="pmid">26189831</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of oligodendrocytes differentiation regulator gene DUSP15 with autism</article-title>
<source/>World J Biol Psychiatry
          <year>2017</year>
<volume>18</volume>
<fpage>143</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1080/15622975.2016.1178395</pub-id>
<pub-id pub-id-type="pmid">27223645</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Euskirchen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ziskin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrated systems analysis reveals a molecular network underlying autism spectrum disorders</article-title>
<source/>Mol Syst Biol
          <year>2014</year>
<volume>10</volume>
<fpage>774</fpage>
<pub-id pub-id-type="doi">10.15252/msb.20145487</pub-id>
<pub-id pub-id-type="pmid">25549968</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardan</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Libove</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Keshavan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Melhem</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism</article-title>
<source/>Biol Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>320</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.04.024</pub-id>
<pub-id pub-id-type="pmid">19520362</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Luders</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hulst</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Narr</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Toga</surname>
<given-names>AW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Total brain volume and corpus callosum size in medication-naive adolescents and young adults with autism spectrum disorder</article-title>
<source/>Biol Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>316</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.03.011</pub-id>
<pub-id pub-id-type="pmid">19409535</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maezawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>LW</given-names>
</name>
</person-group>
<article-title>Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<fpage>5346</fpage>
<lpage>5356</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5966-09.2010</pub-id>
<pub-id pub-id-type="pmid">20392956</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lioy</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Grunseich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology</article-title>
<source/>Nat Neurosci
          <year>2009</year>
<volume>12</volume>
<fpage>311</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2275</pub-id>
<pub-id pub-id-type="pmid">19234456</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuskaitis</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Beurel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of fragile X syndrome</article-title>
<source/>Biochim Biophys Acta
          <year>1802</year>
<volume>2010</volume>
<fpage>1006</fpage>
<lpage>1012</lpage>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>European Medicines Agency (EMA)</collab>
</person-group>
<source/>New measures to avoid valproate exposure in pregnancy endorsed EMA/375438/2018
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranger</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ellenbroek</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Perinatal influences of valproate on brain and behaviour: an animal model for autism</article-title>
<source/>Curr Top BehavNeurosci
          <year>2016</year>
<volume>29</volume>
<fpage>363</fpage>
<lpage>386</lpage>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markram</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rinaldi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>La Mendola</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sandi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Abnormal fear conditioning and amygdala processing in an animal model of autism</article-title>
<source/>Neuropsychopharmacology
          <year>2008</year>
<volume>33</volume>
<fpage>901</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301453</pub-id>
<pub-id pub-id-type="pmid">17507914</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moldrich</surname>
<given-names>RX</given-names>
</name>
<name>
<surname>Leanage</surname>
<given-names>G</given-names>
</name>
<name>
<surname>She</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dolan-Evans</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reza</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice</article-title>
<source/>Behav Brain Res
          <year>2013</year>
<volume>257</volume>
<fpage>253</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2013.09.049</pub-id>
<pub-id pub-id-type="pmid">24103642</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wohr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwarting</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation</article-title>
<source/>Cell Tissue Res
          <year>2013</year>
<volume>354</volume>
<fpage>81</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-013-1607-9</pub-id>
<pub-id pub-id-type="pmid">23576070</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Przewlocki</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism</article-title>
<source/>Neuropsychopharmacology
          <year>2005</year>
<volume>30</volume>
<fpage>80</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300518</pub-id>
<pub-id pub-id-type="pmid">15238991</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Lovic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Madden</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sinopoli</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Maternal and littermate deprivation disrupts maternal behavior and social-learning of food preference in adulthood: tactile stimulation, nest odor, and social rearing prevent these effects</article-title>
<source/>Dev Psychobiol
          <year>2006</year>
<volume>48</volume>
<fpage>209</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="doi">10.1002/dev.20130</pub-id>
<pub-id pub-id-type="pmid">16568415</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Turczak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Przewlocki</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism</article-title>
<source/>Neuropsychopharmacology
          <year>2006</year>
<volume>31</volume>
<fpage>36</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300767</pub-id>
<pub-id pub-id-type="pmid">15920505</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucchina</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Depino</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Altered peripheral and central inflammatory responses in a mouse model of autism</article-title>
<source/>Autism Res
          <year>2014</year>
<volume>7</volume>
<issue>2</issue>
<fpage>273</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1338</pub-id>
<pub-id pub-id-type="pmid">24124122</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Codagnone</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Podestá</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Uccelli</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Reinés</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism</article-title>
<source/>Dev Neurosci
          <year>2015</year>
<volume>37</volume>
<issue>3</issue>
<fpage>215</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1159/000375489</pub-id>
<pub-id pub-id-type="pmid">25895486</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>